IN | Aktsiad | 597,92 M | 1198 | IN Invesco | 0,14 | Tervishoiu | S&P Select Sector Capped 20% Health Care Index | 16.12.2009 | 916,12 | 5,12 | 22,97 |
IN | Aktsiad | 578,89 M | 40 858 | IN Invesco | 0,58 | Tervishoiu | Dynamic Pharmaceutical Intellidex Index (AMEX) | 23.6.2005 | 128,93 | 3,12 | 18,42 |
SP | Aktsiad | 576,25 M | 11 415 | SP SPDR | 0,15 | Tervishoiu | S&P Health Care Select Sector Daily Capped 25/20 Index | 7.7.2015 | 51,00 | 4,86 | 22,63 |
FU | Aktsiad | 532,22 M | — | FU Fullgoal | 0,60 | Tervishoiu | CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross | 16.3.2020 | 0,94 | 0,00 | 0,00 |
VA | Aktsiad | 525,11 M | 9879 | VA VanEck | 0,35 | Tervishoiu | MVIS US Listed Biotech 25 | 20.12.2011 | 255,34 | 4,63 | 23,20 |
GU | Aktsiad | 508,01 M | — | GU Guotai | 0,60 | Tervishoiu | CSI Shanghai-Hong Kong-Shenzhen Innovative Pharmaceutical Industry Index - CNY - Benchmark TR Gross | 8.9.2021 | 0,75 | 3,53 | 27,58 |
CH | Aktsiad | 489,93 M | — | CH ChinaAMC | 0,60 | Tervishoiu | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 23.11.2023 | 0,83 | 2,64 | 31,04 |
SP | Aktsiad | 482,52 M | 166 386 | SP SPDR | 0,35 | Tervishoiu | S&P Pharmaceuticals Select Industry | 19.6.2006 | 64,33 | 3,51 | 16,73 |
IS | Aktsiad | 444,44 M | 58 818 | IS iShares | 0,18 | Tervishoiu | MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped Index - Benchmark TR Net | 3.11.2021 | 5,70 | 4,73 | 22,23 |
| Aktsiad | 444,03 M | — | MO Motilal Oswal | 1,00 | Tervishoiu | BSE Healthcare Index - INR - Benchmark TR Gross | 29.7.2022 | 48,05 | 5,07 | 36,04 |
IN | Aktsiad | 442,23 M | 23 908 | IN Invesco | 0,59 | Tervishoiu | Dynamic Biotech & Genome Intellidex Index (AMEX) | 23.6.2005 | 102,37 | 4,40 | 17,88 |
CS | Aktsiad | 416,91 M | — | CS China Southern | 0,20 | Tervishoiu | CSI Innovative Pharmaceutical Industrial Index - CNY - Benchmark TR Gross | 12.3.2021 | 0,65 | 3,14 | 28,61 |
| Aktsiad | 405,18 M | — | MA Maxwealth | 0,60 | Tervishoiu | CSI Hong Kong Stock Connect Healthcare Index - CNY - Benchmark TR Net | 2.4.2025 | 1,39 | 0,00 | 0,00 |
EV | Aktsiad | 368,85 M | 22 146 | EV Evolve | 0,45 | Tervishoiu | Solactive Global Healthcare 20 CAD Hedged Index - CAD | 23.10.2017 | 18,68 | 4,23 | 21,55 |
AM | Aktsiad | 354,99 M | — | AM Amundi | 0,18 | Tervishoiu | S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care Index - EUR - Benchmark TR Net | 20.9.2022 | 10,66 | 4,64 | 21,76 |
LG | Aktsiad | 353,33 M | 6850 | LG L&G | 0,49 | Tervishoiu | ROBO Global Healthcare Technology and Innovation ETF | 2.7.2019 | 19,14 | 3,12 | 25,07 |
XT | Aktsiad | 351,14 M | 3294 | XT Xtrackers | 0,17 | Tervishoiu | MSCI Europe Health Care ESG Screened 20-35 Index - EUR | 26.6.2007 | 250,07 | 4,15 | 19,55 |
SI | Aktsiad | 340,04 M | 81 167 | SI Simplify | 0,51 | Tervishoiu | | 7.10.2021 | 40,12 | 4,73 | 22,97 |
IS | Aktsiad | 296,57 M | 105 234 | IS iShares | 0,25 | Tervishoiu | Dow Jones U.S. Select Medical Equipment Capped 35/20 Index | 3.8.2020 | 6,03 | 3,74 | 29,19 |
IN | Aktsiad | 292,89 M | 53 631 | IN Invesco | 0,74 | Tervishoiu | Dorsey Wright Healthcare Tech Leaders TR | 12.10.2006 | 58,93 | 5,92 | 26,92 |
HA | Aktsiad | 290,17 M | — | HA Harvest | 0,60 | Tervishoiu | SSE Science and Technology Innovation Board Biomedical Index Yield - CNY - Benchmark TR Net | 27.12.2023 | 1,05 | 0,00 | 0,00 |
| Aktsiad | 285,17 M | — | CA Capital | 1,01 | Tervishoiu | NASDAQ / Biotechnology | 9.1.2017 | 36,06 | 4,93 | 21,18 |
HA | Aktsiad | 272,94 M | 74 653 | HA Harvest | 1,66 | Tervishoiu | | 21.8.2024 | 11,64 | 0,00 | 0,00 |
HA | Aktsiad | 252,9 M | 38 817 | HA Hamilton | 0,65 | Tervishoiu | | 6.2.2024 | 14,75 | 4,53 | 21,67 |
YI | Alternatiivvara | 247,68 M | 323 210 | YI YieldMax | 1,00 | Tervishoiu | | 23.10.2023 | 41,77 | 0,00 | 0,00 |
SP | Aktsiad | 231,29 M | 31 351 | SP SPDR | 0,35 | Tervishoiu | S&P Health Care Services Select Industry | 28.9.2011 | 141,90 | 2,54 | 15,55 |
HF | Aktsiad | 230,12 M | — | HF Harvest Funds | 0,60 | Tervishoiu | CSI Vaccine and Biotechnology Index - CNY - Benchmark TR Gross | 16.2.2023 | 0,69 | 2,19 | 38,23 |
| Aktsiad | 221,23 M | 8668 | SY Sygnia | 0,53 | Tervishoiu | | 6.8.2021 | 35,29 | 4,30 | 21,13 |
TE | Aktsiad | 215,14 M | 26 623 | TE Tema | 0,99 | Tervishoiu | | 14.8.2023 | 42,10 | 6,58 | 19,80 |
PA | Aktsiad | 208,11 M | — | PA Ping An | 0,60 | Tervishoiu | CSI Hong Kong Connect Healthcare - CNY - Benchmark TR Gross | 16.12.2021 | 0,92 | 2,48 | 20,11 |
HA | Aktsiad | 203,39 M | — | HA Harvest | 0,60 | Tervishoiu | CSI Medicine and Health 100 Strategy Index - CNY - Benchmark TR Gross | 24.4.2020 | 0,82 | 2,79 | 22,89 |
HA | Aktsiad | 203,27 M | — | HA Harvest | 0,60 | Tervishoiu | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 7.5.2024 | 1,55 | 2,67 | 20,30 |
DI | Aktsiad | 201,37 M | 63 154 | DI Direxion | 0,94 | Tervishoiu | S&P Health Care Select Sector | 15.6.2011 | 167,81 | 4,83 | 22,47 |
BM | Aktsiad | 195,61 M | 1481 | BM BMO | 0,39 | Tervishoiu | Solactive Equal Weight U.S. Health Care Hedged to Canada Index - CAD | 19.5.2010 | 82,54 | 3,67 | 20,81 |
CH | Aktsiad | 190,36 M | — | CH ChinaAMC | 0,60 | Tervishoiu | CSI Hong Kong Stock Connect Healthcare Index - CNY - Benchmark TR Net | 28.7.2025 | 0,89 | 0,00 | 0,00 |
BE | Aktsiad | 188,43 M | 136 838 | BE BetaShares | 0,57 | Tervishoiu | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | 4.8.2016 | 9,63 | 4,60 | 21,62 |
AF | Aktsiad | 186,97 M | 42 127 | AF ALPS Funds | 0,50 | Tervishoiu | S-Network Medical Breakthroughs Index | 30.12.2014 | 55,81 | 4,17 | 0,00 |
GU | Aktsiad | 180,39 M | — | GU Guotai | 0,00 | Tervishoiu | Hang Seng Biotechnology Index - CNY - Benchmark TR Gross | 21.1.2026 | 1,00 | 0,00 | 0,00 |
IN | Aktsiad | 178,71 M | 25 461 | IN Invesco | 0,29 | Tervishoiu | S&P SmallCap 600 Capped Health Care Index - Benchmark TR Gross | 7.4.2010 | 55,50 | 2,51 | 19,03 |
| Aktsiad | 173,45 M | — | HW Hwabao | 0,60 | Tervishoiu | CSI Hong Kong Connect Healthcare - CNY - Benchmark TR Gross | — | 0,93 | 0,00 | 0,00 |
BO | Aktsiad | 168,87 M | — | BO Bosera | 0,60 | Tervishoiu | CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross | 22.7.2021 | 0,58 | 3,89 | 25,29 |
EF | Aktsiad | 165,58 M | — | EF E Fund | 0,00 | Tervishoiu | Hang Seng Biotech Index - CNY - Benchmark TR Gross | 20.10.2025 | 0,97 | 0,00 | 0,00 |
CH | Aktsiad | 157,24 M | — | CH ChinaAMC | 0,60 | Tervishoiu | | 4.3.2021 | 0,62 | 2,79 | 29,27 |
GU | Aktsiad | 155,73 M | — | GU Guotai | 0,60 | Tervishoiu | China Securities Vaccine and Biotechnology Index - Benchmark TR Gross | 10.8.2022 | 0,58 | 0,00 | 0,00 |
IC | Aktsiad | 155,32 M | — | IC ICBC | 0,52 | Tervishoiu | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 9.2.2021 | 0,57 | 3,14 | 28,61 |
SP | Aktsiad | 152,76 M | 29 287 | SP SPDR | 0,35 | Tervishoiu | S&P Healthcare Equipment Select Industry | 26.1.2011 | 92,58 | 2,50 | 21,37 |
TD | Aktsiad | 147,38 M | 7976 | TD TD | 0,39 | Tervishoiu | Solactive Global Healthcare Leaders Index - CAD - Benchmark TR Net | 7.4.2021 | 22,16 | 3,51 | 20,54 |
MI | Aktsiad | 146,22 M | — | MI Middlefield | 1,36 | Tervishoiu | | 12.2.2019 | 11,40 | 4,83 | 24,11 |
VI | etf_assetclass_Sector Equity | 133,93 M | 11 737 | VI Virtus | 0,34 | Tervishoiu | LifeSci Biotechnology Products Index | 16.12.2014 | 103,02 | 5,54 | 0,00 |
IS | Aktsiad | 133,77 M | 12 297 | IS iShares | 0,18 | Tervishoiu | S&P 500 CAPPED 35/20 HEALTH CARE NTR | 15.6.2020 | 8,32 | 0,00 | 0,00 |
EF | Aktsiad | 132,35 M | — | EF E Fund | 0,60 | Tervishoiu | CSI Hong Kong Stock Connect Healthcare Index - CNY - Benchmark TR Net | 31.12.2025 | 0,86 | 0,00 | 0,00 |
| etf_assetclass_Sector Equity | 131 M | 4480 | CI CIGlobal | 0,72 | Tervishoiu | | 7.6.2018 | 12,02 | 3,88 | 17,87 |
AM | Aktsiad | 125,69 M | — | AM Amundi | 0,18 | Tervishoiu | S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care Index - EUR - Benchmark TR Net | 20.9.2022 | 10,22 | 2,89 | 19,72 |
| Aktsiad | 125,35 M | — | SO SOL | 0,45 | Tervishoiu | FnGuide Medical Device Director Index - KRW - Benchmark Price Return | 22.8.2023 | 9285,07 | 2,31 | 17,09 |
| Aktsiad | 123 M | 4158 | EM Emerald | 0,79 | Tervishoiu | | 30.10.2024 | 44,20 | 6,27 | 0,00 |
IN | Aktsiad | 121,36 M | 36 392 | IN Invesco | 0,19 | Tervishoiu | NASDAQ / Biotechnology | 11.6.2021 | 35,91 | 4,91 | 21,12 |
HA | Aktsiad | 119,27 M | 61 082 | HA Harvest | 2,15 | Tervishoiu | | 25.10.2022 | 9,19 | 0,00 | 0,00 |
FU | Aktsiad | 116,43 M | — | FU Fullgoal | 0,60 | Tervishoiu | Hang Seng Biotech Index - CNY - Benchmark TR Gross | 24.12.2025 | 1,00 | 0,00 | 0,00 |
CS | Aktsiad | 114,35 M | — | CS China Southern | 0,60 | Tervishoiu | CSI Full Index of Medical and Healthcare Equipment and Service Index - CNY - Benchmark TR Gross | 22.10.2021 | 0,56 | 2,73 | 32,82 |
RG | Aktsiad | 112,95 M | 47 451 | RG ROBO Global | 0,80 | Tervishoiu | ROBO Global Healthcare Technology and Innovation ETF | 25.6.2019 | 45,63 | 3,10 | 25,46 |
KR | Aktsiad | 112,65 M | 82 189 | KR KraneShares | 0,79 | Tervishoiu | MSCI China All Shares Health Care 10/40 Index | 31.1.2018 | 18,32 | 3,41 | 26,60 |
PR | Aktsiad | 112,47 M | 14 420 | PR ProShares | 1,08 | Tervishoiu | S&P Health Care Select Sector | 30.1.2007 | 69,43 | 0,00 | 0,00 |
HE | Aktsiad | 104,2 M | — | HE Harvest ETFs | 1,06 | Tervishoiu | | 17.1.2017 | 7,83 | 0,00 | 0,00 |
PR | Aktsiad | 102,17 M | 10 089 | PR ProShares | 1,17 | Tervishoiu | NASDAQ / Biotechnology | 7.4.2010 | 118,80 | 0,00 | 0,00 |
| Aktsiad | 100,55 M | — | SA Satrix | 0,48 | Tervishoiu | STOXX Global Breakthrough Healthcare (USD)(NR) | 26.5.2022 | 73,03 | 0,00 | 0,00 |
| Aktsiad | 94,92 M | 469 | FI FirstRand | 0,00 | Tervishoiu | Eli Lilly and Co. - USD - Benchmark Price Return | 25.4.2024 | 18,98 | 0,00 | 0,00 |
MI | Aktsiad | 84,3 M | 1274 | MI Middlefield | 0,85 | Tervishoiu | | 21.7.2017 | 10,44 | 0,00 | 0,00 |
CI | Aktsiad | 82,21 M | — | CI CI | 0,56 | Tervishoiu | Solactive Developed Markets Healthcare 150 CAD Index - CAD - Benchmark TR Net | 17.8.2021 | 23,70 | 0,00 | 0,00 |
| Aktsiad | 81,79 M | 1185 | FI FirstRand | 1,00 | Tervishoiu | Eli Lilly and Co. - USD - Benchmark Price Return | 25.4.2024 | 16,36 | 0,00 | 0,00 |
CA | Aktsiad | 78,35 M | — | CA Cathay | 0,00 | Tervishoiu | ChiNext Medical and Healthcare Index - CNY - Benchmark TR Net | 2.4.2025 | 1,07 | 0,00 | 0,00 |
| Aktsiad | 78,23 M | — | KS KSM | 0,73 | Tervishoiu | S&P Health Care Select Sector | 4.12.2018 | 48,79 | 0,00 | 0,00 |
IS | Aktsiad | 77,93 M | 35 899 | IS iShares | 0,35 | Tervishoiu | NASDAQ / Biotechnology | 5.3.2018 | 10,52 | 4,93 | 21,38 |
BF | Aktsiad | 72,72 M | 3137 | BF Brompton Funds | 0,75 | Tervishoiu | | 24.9.2015 | 7,84 | 6,13 | 23,54 |
| Aktsiad | 67,67 M | 714 778 | LE LeverageShares | 0,75 | Tervishoiu | | 22.7.2025 | 20,29 | 0,00 | 0,00 |
CH | Aktsiad | 62,41 M | — | CH ChinaAMC | 0,00 | Tervishoiu | Shanghai Stock Exchange Science and Technology Innovation Board Biopharmaceutical Index - CNY - Benchmark TR Gross | 14.5.2025 | 1,08 | 0,00 | 0,00 |
DI | etf_assetclass_Leveraged/Inverse | 61,82 M | 19,01 M | DI Direxion | 1,08 | Tervishoiu | S&P Biotechnology Select Industry | 28.5.2015 | 6,98 | 0,00 | 0,00 |
RI | Aktsiad | 57,26 M | 18 104 | RI Roundhill Investments | 0,59 | Tervishoiu | | 21.5.2024 | 31,29 | 4,01 | 14,05 |
TE | Aktsiad | 57,23 M | 3935 | TE Tema | 0,99 | Tervishoiu | | 20.11.2023 | 38,67 | 6,56 | 21,55 |
FI | Aktsiad | 52,31 M | 8355 | FI Fidelity | 0,50 | Tervishoiu | | 16.4.2020 | 33,13 | 4,23 | 37,59 |
VA | Aktsiad | 50,79 M | — | VA VanEck | 0,45 | Tervishoiu | MarketGrader Developed Markets ex-Australia Health Care Index - AUD | 8.9.2020 | 11,35 | 4,95 | 21,34 |
GX | Aktsiad | 48,57 M | 2111 | GX Global X | 0,45 | Tervishoiu | S&P Biotechnology Select Industry | 8.11.2018 | 75,41 | 5,08 | 0,00 |
MI | Aktsiad | 45,87 M | 33 | MI Middlefield | 0,27 | Tervishoiu | | 20.10.2016 | 12,33 | 4,47 | 21,53 |
HA | Aktsiad | 45,64 M | 4437 | HA Harbor | 0,80 | Tervishoiu | | 16.11.2022 | 36,26 | 11,65 | 33,30 |
DE | Aktsiad | 44,92 M | 349 081 | DE Defiance | 1,33 | Tervishoiu | | 12.3.2025 | 19,04 | 0,00 | 0,00 |
AD | Aktsiad | 42,59 M | 37 284 | AD AdvisorShares | 1,28 | Tervishoiu | | 15.9.2021 | 19,76 | 3,48 | 0,00 |
FU | Aktsiad | 40,7 M | — | FU Fullgoal | 0,60 | Tervishoiu | CSI Vaccine and Biotechnology Index - CNY - Benchmark TR Gross | 16.9.2022 | 0,66 | 2,00 | 29,03 |
DE | etf_assetclass_Leveraged/Inverse | 39,87 M | 317 096 | DE Defiance | 1,49 | Tervishoiu | | 7.8.2024 | 35,13 | 0,00 | 0,00 |
IS | Aktsiad | 38,78 M | 7141 | IS iShares | 0,18 | Tervishoiu | | 21.3.2018 | 41,39 | 4,27 | 23,49 |
SP | Aktsiad | 37,63 M | 44 470 | SP SPDR | 0,35 | Tervishoiu | S&P Health Care Select Sector | 29.7.2025 | 27,07 | 0,00 | 0,00 |
IS | Aktsiad | 36,79 M | 3797 | IS iShares | 0,18 | Tervishoiu | | 21.3.2018 | 34,13 | 5,85 | 16,28 |
DE | Aktsiad | 36,42 M | 395 771 | DE Defiance | 1,31 | Tervishoiu | | 2.12.2024 | 10,38 | 0,00 | 0,00 |
PU | Aktsiad | 36,24 M | — | PU Purpose | 0,00 | Tervishoiu | | 7.2.2025 | 7,98 | 0,00 | 0,00 |
GX | Aktsiad | 35,21 M | 10 183 | GX Global X | 0,50 | Tervishoiu | Global X HealthTech Index - Benchmark TR Net | 29.7.2020 | 30,62 | 3,67 | 26,47 |
| Aktsiad | 34,5 M | 7692 | TR T. Rowe | 0,44 | Tervishoiu | | 11.6.2025 | 34,50 | 3,97 | 25,60 |
VI | etf_assetclass_Sector Equity | 34,28 M | 25 511 | VI Virtus | 0,65 | Tervishoiu | LifeSci Biotechnology Clinical Trials Index | 16.12.2014 | 42,85 | 4,22 | 0,00 |
EV | Aktsiad | 32,67 M | — | EV Evolve | 0,72 | Tervishoiu | Solactive Global Healthcare 20 Index - CAD | 25.10.2017 | 22,60 | 0,00 | 0,00 |
SM | etf_assetclass_Sector Equity | 32,38 M | 13 219 | SM Smartshares | 0,75 | Tervishoiu | STOXX Global Breakthrough Healthcare (USD)(NR) | 6.6.2019 | 4,47 | 0,00 | 0,00 |
| Aktsiad | 31,72 M | — | TA Tachlit | 1,23 | Tervishoiu | NASDAQ / Biotechnology | 13.11.2018 | 152,42 | 0,00 | 0,00 |
TR | Aktsiad | 30,91 M | 246 159 | TR Tradr | 1,30 | Tervishoiu | | 12.5.2025 | 30,51 | 0,00 | 0,00 |
HE | Aktsiad | 30,63 M | — | HE Harvest ETFs | 0,00 | Tervishoiu | | 21.8.2024 | 9,22 | 0,00 | 0,00 |